CTCR-MVS Trial

Dr. Nav Malhi presented the CTCR-MVS Trial, which is a randomized, surgical trial comparing mitral valve surgery with or without tricuspid annuloplasty (TA) among patients who were undergoing mitral-valve surgery for degenerative mitral regurgitation with either moderate tricuspid regurgitation or less-than-moderate regurgitation with annular dilatation of 40 mm or more. The primary end point at 2 years was a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.